Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Acta Dermato-Venereologica
|
April 27, 2021
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
Antonio Costanzo, Filomena Russo, Marco Galluzzo, et al.
Dermatology and Therapy
|
September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy
|
February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)
Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
June 5, 2025
<i>Letter:</i> Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD
Giuseppe Lauletta, Luca Potestio, Cataldo Patruno, et al.
Journal of Clinical Medicine
|
May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing
Francesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Dermatology Practical & Conceptual
|
March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' Lives
Stefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Dermatology and Therapy
|
July 3, 2025
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis)
Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Clinical Medicine
|
May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Clinical Medicine
|
January 11, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis
Francesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.
Clinical and Experimental Dermatology
|
November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Acta Dermato-Venereologica
|
April 27, 2021
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
Antonio Costanzo, Filomena Russo, Marco Galluzzo, et al.
Dermatology and Therapy
|
September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy
|
February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)
Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
June 5, 2025
<i>Letter:</i> Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD
Giuseppe Lauletta, Luca Potestio, Cataldo Patruno, et al.
Journal of Clinical Medicine
|
May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing
Francesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Dermatology Practical & Conceptual
|
March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' Lives
Stefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Dermatology and Therapy
|
July 3, 2025
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis)
Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
Journal of Clinical Medicine
|
May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Clinical Medicine
|
January 11, 2024
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis
Francesca Prignano, Giuseppe Argenziano, Federico Bardazzi, et al.
Clinical and Experimental Dermatology
|
November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.
Page
of 8